Why the study?
Does transgenic overexpression of Ca(2+)-stimulatable adenylyl cyclase type 8 (AC8) in the heart alter cardiac function in mice?
Does transgenic overexpression of Ca(2+)-stimulatable adenylyl cyclase type 8 (AC8) in the heart alter cardiac function in mice?
Transgenic mice expressing AC8 in the heart demonstrate enhanced intrinsic contractility, providing a novel model to investigate the relative influence of Ca2+ and cAMP on cardiac function.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open AC8 transgenic mice as a model to probe Ca2+-cAMP effects on contractility.
The predominant functional adenylyl cyclases normally expressed in cardiac tissue and coupled to beta-adrenergic receptors are inhibited by micromolar Ca(2+) concentration. To modify the overall balance of activities, we have generated transgenic mice expressing the Ca(2+)-stimulatable adenylyl cyclase type 8 (AC8) specifically in the heart. AC activity is increased by at least 7-fold in heart membranes from transgenic animals and is stimulated by Ca(2+) in the same range of concentration that inhibits the endogenous activity. Moreover, the in vivo basal protein kinase A activity was augmented 4-fold. Overexpression of AC8 in the heart has no detrimental consequences on global cardiac function. Basal heart rate and contractile function, measured by noninvasive echocardiography, were unchanged. In contrast, on release of parasympathetic tone, the intrinsic contractility is heightened and unresponsive to further beta-adrenergic receptor stimulation. AC8 transgenic mice thus represent an original model to investigate the relative influence of Ca(2+) and cAMP on cardiac function within a phenotype of enhanced cardiac contractility and relaxation.
No takes yet. Share an insight, caveat, or question.
Lipskaia et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: